The costs of interdigital phlegmon in four loose-housed Finnish dairy herds by Häggman, Johanna et al.
Häggman et al. Acta Vet Scand  (2015) 57:90 
DOI 10.1186/s13028-015-0181-4
BRIEF COMMUNICATION
The costs of interdigital phlegmon 
in four loose-housed Finnish dairy herds
Johanna Häggman1*, Reijo Junni2, Heli Simojoki3, Jarmo Juga1 and Timo Soveri3
Abstract 
Background: The aim of the study was to provide detailed herd level cost information about an outbreak of interdig-
ital phlegmon (IP), which has been an emerging problem with enlarged loose house barns in Finland in recent years. 
During enlargement, the farmer’s financial situation is sensitive because of the large investments to the farm business 
and unexpected costs can risk the farm’s survival.
Results: The University of Helsinki research herd and three commercial herds having outbreaks of IP in 2012 or 2013 
were visited to collect detailed information about the costs and economic impact of the outbreaks. The majority of 
the costs came from the discarded milk due to the antibiotic treatments. In Finland IP is usually treated with parental 
benzylpenicillin for 5 days which result in discarded milk for a total of 11 days. Third generation cephalosporins, widely 
used in other countries, have no milk withdrawal time. However, the use of these antibiotics is not recommended in 
Finland since these antimicrobials are critically important for human health. Herd-level costs varied between 4560 
and 28,386 € depending on the herd size, the frequency of the infected cows, the antibiotics used and other costs 
involved. The average cost per infected cow was 489 €.
Conclusions: The outbreaks of IP cause severe economic losses to dairy farms and the costs are lower if cows are 
treated with antibiotics with no withdrawal time. However, other costs, such as involuntary culling, reduced produc-
tion and fertility also produce substantial costs to the farms. Early detection of sick animals, rapid treatment and 
control measures to limit the outbreak of IP can lower the costs. Because of the high costs farms should concentrate 
on preventing the disease.
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Findings
Interdigital phlegmon (IP) or foot rot is a necrotizing 
soft tissue inflammation in the interdigital region of the 
foot [1–3]. IP is believed to be a mixed infection of mul-
tiple anaerobic pathogens, such as Fusobacterium necro-
phorum (which is believed to be the primary pathogen), 
Dichelobacter nodus, Porphyromonas levii, P. asaccharo-
lytica, Prevotella intermedia, and P. melaninogenica [3, 
4]. However, the exact pathogenic mechanisms of these 
bacteria are still not determined. F. necrophorum is com-
monly found in the soil and can be isolated on the feet, 
rumen and feces of healthy cows [3], hence injury to the 
skin of the interdigital area can predispose the cow to 
IP [2]. In recent years, outbreaks of IP have occurred in 
Finnish dairy farms. IP is painful, causes lameness, and 
is also a costly disease, which can have a serious impact 
on the farm profitability. Specifically, the effect of the dis-
ease is dramatic if the majority of the cows in a herd are 
infected.
In Finland IP is usually treated with parenteral ben-
zylpenicillin for 5  days (20  mg/kg) with a milk with-
drawal time of 6 days, which results in discarded milk of 
a total of 11 days. Additionally, cows are usually treated 
with non-steroidal anti-inflammatory drugs and in some 
cases foot baths for the healthy cows are recommended 
for controlling the infection in the herd. If IP is diagnosed 
and treated early the antibiotic treatment is usually suc-
cessful and most cases respond rapidly [1], whereas the 
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response to delayed antibiotic treatment can fail to con-
trol the infection and in the worst case the cow has to be 
culled [5]. Permanent working group on the antimicro-
bials of the Ministry of Agriculture and Forestry in Fin-
land has set guidelines for antimicrobial treatments of 
common diseases in animals. The primary antimicrobial 
recommendation for IP is use of narrow-spectrum anti-
biotic benzylpenicillin and the secondary use of oxytet-
racycline or macrolides [6]. Ceftiofur, a third generation 
cephalosporin, does not have a milk withdrawal time 
and is available in Finland. However, as it belongs to the 
group of antimicrobials, which is identified by the World 
Health Organization (WHO) as critically important for 
human health, the use of this antimicrobial is not recom-
mended since its impact to antimicrobial resistance [7]. 
According to the one health perspective, Nordic coun-
tries have managed to keep the prevalence of antibiotic 
resistant at a low level which is important to maintain 
the effectiveness of these antibiotics also in the future. If 
the effectiveness of these antibiotics is lost there will be 
a need to develop a new medicine which is turned out to 
be challenging.
The aim of this study was to provide detailed cost infor-
mation about an outbreak of IP at the herd level. Such 
information is not possible to obtain from the standard 
Finland health or economic recording and no previous 
studies have been undertaken to compile the economic 
costs associated with an IP outbreak.
The costs presented in this study do not include taxes 
(VAT 0 %). In the University research farm the accurate 
daily discarded milk yields were available. In the other 
farms losses due to the discarded milk were calculated 
based on the number of the clinical cases of IP, the milk 
yield (my) in the previous test day recording before the 
clinical case of IP was diagnosed, the wait time (wt) due 
to antibiotic use and the milk price (mp) at that time.
 The veterinary costs were calculated based on the num-
ber of veterinarian visits and the costs of treatment per 
clinical case including all veterinary fees (vf) and medi-
cines (m).
 The labor costs were calculated based on time spent (ts) 
on the clinical case and the hourly wage claim (wc) of the 
dairy farmer in 2013 in Finland (14.90  €) [8]. The esti-
mated daily time spent for a clinical case was 15 min/cow 
for farms A, C and D and 30 min/cow for farm B.
Milk =
n∑
i=0
(
my× wt ×mp
)
Veterinarian =
n∑
i=0
(
vf +m
)
 The costs for special claw trimmings were calculated 
based on the number of the claw trimmings due to clini-
cal cases and the rate of the trimming (rt).
 The cost of an involuntary culled cows and lost calves 
were calculated based on the total number of culled 
cows and lost calves, the transportation cost (tc), the 
price of the culled cows (pc) which varied between 500 
and 1250 € depending on the parity, milk yield and fertil-
ity status and the price of the lost calves (plc) which was 
100 €/calf.
Other costs, such as the increased use of copper sulfate 
in the foot baths, were also included. IP can also lower 
the milk production, prolong the calving interval and 
predispose cows to other diseases [5]. A decrease in milk 
production was not noted in this study. The information 
about the cost of the prolonged calving interval was not 
available and was not included in this study. However, an 
average dairy cow with a clinical foot disorder has a pro-
longed calving interval of 12 days [9] and in Finland the 
daily cost for each open day is about 2.5 € [10].
University of Helsinki research herd (A) and three com-
mercial loose-housed herds (B–D) having outbreaks of IP 
in 2012 or 2013 were visited to collect detailed informa-
tion about the costs and economic impact of the outbreak. 
These farms had not had IP outbreaks before and the pre-
vious status of other infectious claw disorders was compa-
rable to other farms in Finland. The commercial farms had 
already participated in the “Infectious hoof diseases in dairy 
cows in new loose housing system” project funded by the 
Ministry of Agriculture and Forestry. The researcher visited 
the farms at the beginning of the outbreaks and diagnosed 
IP based on clinical signs (body temperature, appearance 
and site of the lesion, swelling, odour, lameness) and bac-
teriology. Later IP cases at the farm were diagnosed by the 
local veterinarian. Farm location, number of cows, number 
of cows treated and antimicrobials used are described in 
Table 1 and the cost sources are described in Table 2.
The costs varied between the farms (Table  2), herd-
level costs being the highest in the University research 
farm (A), where the costs due to the discarded milk were 
high when the majority of the cows were infected, milk 
production was high and cows were treated with regular 
Labor =
n∑
i=0
(ts × wc)
Trimming =
n∑
i=0
rt
Culled_animals =
n∑
i=0
(tc + pc + plc).
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antibiotics. In two study herds (C and D), however, cows 
were treated with ceftiofur (Table 1) and milk losses were 
not severe as some veterinarians use it despite the recom-
mendations. The average cost per infected cow was 489 €, 
the lowest costs in farm D where the majority of the cows 
were infected and half of them were treated with ceftio-
fur. In farm B only a small number of cows were infected 
and the total costs were low which could be due to the 
early detection of the disease and the fact that affected 
cows were isolated from the rest of the herd during the 
early infectious stages. All the cows in farm B were moni-
tored carefully and closely inspected if something abnor-
mal was observed. In farm C, seven calves were lost and 
four cows had to be culled producing extra costs.
IP epidemics cause economic losses to dairy industry 
and the majority of the costs come from the discarded milk 
due to the treatments with antibiotics. Also, other costs 
involved (involuntary culling, reduced production and fer-
tility) are substantial. However, rapid treatment and con-
trol measures to limit the outbreak of IP will greatly reduce 
the total herd cost. Based on this study the average cost per 
infected cow can be assumed to be 600–700 € when the 
cow is treated with benzylpenicillin. Because of high costs 
of IP it would be more efficient on the economic point of 
view to focus on the prevention of the disease.
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Table 1 Farm location, number of cows, number of cows treated and antimicrobials used
a Ethacillin vet, MSD Animal Health, Finland, dose 20,000 IU/kg once a day 5 days
b Engemycin LA vet, MSD Animal Health, Finland, dose 10 mg/kg 5 days
c Penovet vet, Vetcare, Finland, dose 20 mg/kg once a day 5 days
d Geepenil vet, Orion, Finland, dose 10 mg/kg, twice a day 4 days
e Cefenil vet, Vetmedic Animal Health OY, Finland, dose 1 mg/kg, once a day 3 days
Farm, location Cows total (n) Infected cows (n) Antimicrobials used during IP outbreak
A, Southern Finland 65 50 71 treatments: benzylpenicillina (300,000 IU/ml)
1 treatment: oxytetracyclineb (100 mg/ml)
B, Central Finland 40 7 4 treatments: oxytetracyclineb (100 mg/ml)
6 treatments: benzylpenicillinc (300 mg/ml)
C, Northern Ostrobothnia 80 36 22 treatments: benzylpenicillin natriumd (24 g)
18 treatments: benzylpenicillinc (300 mg/ml)
4 treatments: benzylpenicillina (300,000 IU/ml)
11 treatments: ceftiofure (50 mg/ml)
D, Central Finland 85 68 6 treatments: oxytetracyclineb (100 mg/ml)
32 treatments: benzylpenicillinc (300 mg/ml)
37 treatments ceftiofure (50 mg/ml)
Table 2 The percentage of  infected cows, herd-level costs 
(€) and costs divided with the number of infected cows
a cost of medicines included
Farm A B C D
Infected cows (%) 77 18 45 80
Cost due to discarded milk 19,989.1 1702.2 6135.5 5865.7
Veterinary costa 7056.1 1133.0 5000.0 6621.3
Extra labor cost 1341.0 678.0 1385.7 1825.3
Extra claw trimming cost 1047.0 500.0 1371.5
Costs due to culling 3820.0
Other costs 900.0 1033.0
Total cost 28,386.2 4560.2 17,741.2 16,716.6
Total cost/infected cow 567.7 651.5 492.8 245.8
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